DSM figures: five-year summary
All figures are including discontinued operations unless stated otherwise, see also Note 3 Change in the scope of the consolidation.
x € million |
|
2022 |
|
2021 |
|
2020 |
|
2019 |
|
2018 |
---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
Intangible assets |
|
5,147 |
|
5,309 |
|
4,440 |
|
3,515 |
|
3,090 |
Property, plant and equipment |
|
3,576 |
|
3,964 |
|
3,775 |
|
4,040 |
|
3,511 |
Deferred tax assets |
|
95 |
|
203 |
|
240 |
|
217 |
|
248 |
Share in associates and joint ventures |
|
61 |
|
64 |
|
93 |
|
155 |
|
205 |
Derivatives |
|
82 |
|
48 |
|
61 |
|
27 |
|
14 |
Other financial assets |
|
314 |
|
302 |
|
317 |
|
265 |
|
263 |
Non-current assets |
|
9,275 |
|
9,890 |
|
8,926 |
|
8,219 |
|
7,331 |
|
|
|
|
|
|
|
|
|
|
|
Inventories |
|
2,339 |
|
2,297 |
|
1,879 |
|
2,019 |
|
1,993 |
Current receivables |
|
1,622 |
|
1,697 |
|
1,483 |
|
1,698 |
|
1,738 |
Derivatives |
|
42 |
|
30 |
|
48 |
|
19 |
|
21 |
Current investments |
|
125 |
|
489 |
|
43 |
|
688 |
|
1,277 |
Cash and cash equivalents |
|
2,755 |
|
1,561 |
|
871 |
|
800 |
|
1,281 |
Assets held for sale |
|
1,245 |
|
56 |
|
1,096 |
|
- |
|
- |
Current assets |
|
8,128 |
|
6,130 |
|
5,420 |
|
5,224 |
|
6,310 |
Total assets |
|
17,403 |
|
16,020 |
|
14,346 |
|
13,443 |
|
13,641 |
|
|
|
|
|
|
|
|
|
|
|
Equity and liabilities |
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity |
|
10,743 |
|
9,318 |
|
7,399 |
|
7,731 |
|
7,782 |
Non-controlling interests |
|
102 |
|
79 |
|
88 |
|
104 |
|
33 |
Equity |
|
10,845 |
|
9,397 |
|
7,487 |
|
7,835 |
|
7,815 |
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities |
|
476 |
|
490 |
|
431 |
|
296 |
|
254 |
Employee benefit liabilities |
|
241 |
|
323 |
|
414 |
|
413 |
|
413 |
Provisions |
|
74 |
|
96 |
|
123 |
|
120 |
|
116 |
Borrowings |
|
2,978 |
|
2,995 |
|
3,484 |
|
2,464 |
|
2,272 |
Derivatives |
|
4 |
|
9 |
|
1 |
|
7 |
|
3 |
Other non-current liabilities |
|
205 |
|
280 |
|
163 |
|
145 |
|
197 |
Non-current liabilities |
|
3,978 |
|
4,193 |
|
4,616 |
|
3,445 |
|
3,255 |
|
|
|
|
|
|
|
|
|
|
|
Employee benefits liabilities |
|
22 |
|
21 |
|
42 |
|
43 |
|
46 |
Provisions |
|
50 |
|
68 |
|
61 |
|
48 |
|
37 |
Borrowings |
|
86 |
|
103 |
|
102 |
|
189 |
|
380 |
Derivatives |
|
23 |
|
40 |
|
13 |
|
18 |
|
51 |
Current liabilities |
|
1,969 |
|
2,188 |
|
1,771 |
|
1,865 |
|
2,057 |
Liabilities held for sale |
|
430 |
|
10 |
|
254 |
|
- |
|
- |
Current liabilities |
|
2,580 |
|
2,430 |
|
2,243 |
|
2,163 |
|
2,571 |
Total equity and liabilities |
|
17,403 |
|
16,020 |
|
14,346 |
|
13,443 |
|
13,641 |
x € million |
|
2022 |
|
2021 |
|
2020 |
|
2019 |
|
2018 |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net sales |
|
10,480 |
|
9,468 |
|
9,038 |
|
9,010 |
|
8,8521 |
||||||
Net sales from continuing operations |
|
8,390 |
|
7,269 |
|
- |
|
- |
|
- |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Adjusted EBITDA2 |
|
1,725 |
|
1,842 |
|
1,650 |
|
1,684 |
|
1,5321 |
||||||
EBITDA |
|
2,646 |
|
2,370 |
|
1,476 |
|
1,586 |
|
1,754 |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Adjusted operating profit (EBIT)2 |
|
1,071 |
|
1,167 |
|
1,011 |
|
1,075 |
|
1,0551 |
||||||
Operating profit (EBIT) |
|
1,994 |
|
1,689 |
|
736 |
|
954 |
|
1,245 |
||||||
Operating profit (EBIT) from continuing operations |
|
682 |
|
711 |
|
- |
|
- |
|
- |
||||||
Financial income and expense |
|
(94) |
|
(106) |
|
(67) |
|
(92) |
|
(101) |
||||||
Income tax expense |
|
(190) |
|
(245) |
|
(129) |
|
(152) |
|
(194) |
||||||
Share of the profit of associates and joint ventures |
|
5 |
|
342 |
|
(32) |
|
54 |
|
129 |
||||||
Net profit for the year |
|
1,715 |
|
1,680 |
|
508 |
|
764 |
|
1,079 |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Net profit attributable to non-controlling interests |
|
15 |
|
4 |
|
2 |
|
6 |
|
2 |
||||||
Net profit available to equity holders of Koninklijke DSM N.V. |
|
1,700 |
|
1,676 |
|
506 |
|
758 |
|
1,077 |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Dividend on Cumulative Preference Shares |
|
(6) |
|
(6) |
|
(7) |
|
(8) |
|
(8) |
||||||
Net profit available to holders of ordinary shares |
|
1,694 |
|
1,670 |
|
499 |
|
750 |
|
1,069 |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Key figures and financial ratios |
|
|
|
|
|
|
|
|
|
|
||||||
Capital employed |
|
11,473 |
|
11,019 |
|
10,557 |
|
9,311 |
|
8,181 |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Capital expenditure: |
|
|
|
|
|
|
|
|
|
|
||||||
- Intangible assets and Property, plant and equipment |
|
636 |
|
614 |
|
622 |
|
623 |
|
653 |
||||||
- Acquisitions |
|
77 |
|
754 |
|
1,579 |
|
585 |
|
50 |
||||||
Disposals |
|
1,413 |
|
1,941 |
|
46 |
|
44 |
|
335 |
||||||
Depreciation, amortization and impairments |
|
652 |
|
681 |
|
740 |
|
632 |
|
509 |
||||||
Net debt |
|
(87) |
|
(1,019) |
|
(2,577) |
|
(1,144) |
|
(113) |
||||||
Dividend |
|
167 |
|
438 |
|
420 |
|
425 |
|
412 |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Workforce at 31 December, headcount |
|
20,682 |
|
21,358 |
|
23,127 |
|
22,174 |
|
20,977 |
||||||
Employee benefit costs (x € million) |
|
1,910 |
|
1,853 |
|
1,848 |
|
1,811 |
|
1,753 |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
Financial ratios2 |
|
|
|
|
|
|
|
|
|
|
||||||
ROCE in % |
|
9.3 |
|
11.1 |
|
10.3 |
|
12.0 |
|
13.31 |
||||||
Net sales/average capital employed |
|
0.91 |
|
0.93 |
|
0.92 |
|
1.01 |
|
1.111 |
||||||
Current assets/current liabilities |
|
3.15 |
|
2.52 |
|
2.42 |
|
2.42 |
|
2.45 |
||||||
Equity/total assets |
|
0.62 |
|
0.59 |
|
0.52 |
|
0.58 |
|
0.57 |
||||||
Gearing (net debt/equity plus net debt) |
|
0.01 |
|
0.10 |
|
0.26 |
|
0.13 |
|
0.01 |
||||||
Adjusted EBIT/net sales in % |
|
10.2 |
|
12.4 |
|
11.2 |
|
11.9 |
|
11.91 |
||||||
Net profit/average Shareholders’ equity available to holders of ordinary shares in % |
|
17.3 |
|
20.5 |
|
6.8 |
|
10.0 |
|
24.7 |
||||||
Adjusted EBITDA/financial income and expense |
|
20.1 |
|
17.4 |
|
24.6 |
|
18.3 |
|
15.21 |
||||||
|
per ordinary share in € |
|
2022 |
|
2021 |
|
2020 |
|
2019 |
|
2018 |
---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Adjusted net profit |
|
4.49 |
|
5.03 |
|
4.43 |
|
4.64 |
|
5.84 |
Net profit |
|
9.80 |
|
9.67 |
|
2.91 |
|
4.27 |
|
6.10 |
Operating cash flow |
|
5.58 |
|
8.23 |
|
8.67 |
|
7.84 |
|
7.89 |
|
|
|
|
|
|
|
|
|
|
|
Dividend: |
|
0.93 |
|
2.50 |
|
2.40 |
|
2.40 |
|
2.30 |
- Interim dividend |
|
0.93 |
|
0.80 |
|
0.80 |
|
0.77 |
|
0.77 |
- Final dividend |
|
- |
|
1.70 |
|
1.60 |
|
1.63 |
|
1.53 |
|
|
|
|
|
|
|
|
|
|
|
Pay-out including dividend on Cumulative Preference Shares as % of Adjusted net profit |
|
21 |
|
50 |
|
55 |
|
52 |
|
40 |
Dividend yield (dividend as % of average price of an ordinary DSM share) |
|
1.2 |
|
2.7 |
|
1.9 |
|
2.3 |
|
2.7 |
|
|
|
|
|
|
|
|
|
|
|
Share prices on Euronext Amsterdam (closing price): |
|
|
|
|
|
|
|
|
|
|
- Highest price |
|
198.70 |
|
199.40 |
|
148.55 |
|
117.90 |
|
92.98 |
- Lowest price |
|
111.80 |
|
136.55 |
|
87.52 |
|
69.54 |
|
68.98 |
- At 31 December |
|
114.30 |
|
198.00 |
|
140.80 |
|
116.10 |
|
71.44 |
|
|
|
|
|
|
|
|
|
|
|
Number of ordinary shares outstanding (x 1,000): |
|
|
|
|
|
|
|
|
|
|
- At 31 December |
|
173,075 |
|
172,969 |
|
172,219 |
|
172,449 |
|
175,651 |
- Average |
|
172,827 |
|
172,648 |
|
171,536 |
|
175,731 |
|
175,323 |
|
|
|
|
|
|
|
|
|
|
|
Daily trading volumes on Euronext Amsterdam: |
|
|
|
|
|
|
|
|
|
|
- Average |
|
435 |
|
331 |
|
518 |
|
635 |
|
732 |
- Lowest |
|
177 |
|
31 |
|
64 |
|
75 |
|
130 |
- Highest |
|
1,799 |
|
914 |
|
1,900 |
|
2,242 |
|
2,617 |